Document is current
Any future updates will be listed below
-
Authors
Williams, Thomas L. https://orcid.org/0000-0002-1051-0595
Verdon, Grégory
Kuc, Rhoda E.
Currinn, Heather
Bender, Brian
Solcan, Nicolae
Schlenker, Oliver
Macrae, Robyn G. C.
Brown, Jason
Schütz, Marco
Zhukov, Andrei
Sinha, Sanjay https://orcid.org/0000-0001-5900-1209
de Graaf, Chris
Gräf, Stefan https://orcid.org/0000-0002-1315-8873
Maguire, Janet J. https://orcid.org/0000-0002-9254-7040
Brown, Alastair J. H.
Davenport, Anthony P. https://orcid.org/0000-0002-2096-3117
-
Funding
Funding for this research was provided by:
Wellcome Trust (203814/Z/16/A, 203814/Z/16/A)
British Heart Foundation (FS/17/61/33473, TG/18/4/33770, TG/18/4/33770, FS/17/61/33473, FS/18/46/33663, TG/18/4/33770)
Nxera (Sosei Heptares) ORBIT Research Grant Cambridge Biomedical Research Centre Biomedical Resources Grant
- License Information
-
More Information
Article History
Received: 19 February 2024
Accepted: 10 December 2024
First Online: 27 December 2024
Competing interests
: G.V., H.C., B.B., N.S., O.S., J.B., M.S., A.Z., and A.J.H.B. are employees of Nxera Pharma UK Limited (Sosei Heptares) and C.d.G. and S.M. are former employees. A.P.D. and J.J.M. were in receipt of a Nxera Pharma UK Limited ORBIT Research Grant. S.G. is co-chair of the International Consortium for Genetic Studies in International Consortium for Genetic Studies in Pulmonary (Arterial) Hypertension. All other authors declare no competing interests.
